Skip to content

JNJ

JOHNSON & JOHNSON

NYSE · Healthcare · Drug Manufacturers - General · US

$269.99
−0.09%
Ask drillr
Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open
$268.47
From 52W high
−3.03%
Volume
15.93M
Market cap
$650.65B
P/E (Fwd)
22.7x
EV/EBITDA
20.1x
P/E (TTM)
31.2x
RSI (14)
53.7
1D Return
−0.09%
YTD Return
+30.19%
SummaryUpdated Jun 1, 2026

Johnson & Johnson (NYSE:JNJ) is one of the world's largest and most diversified healthcare companies, founded in 1886 by the Johnson brothers in New Brunswick, New Jersey. Originally starting as a manufacturer of ready-to-use sterile surgical dressings, the company has evolved over nearly 140 years into a global healthcare conglomerate. Today, J&J operates as a two-sector company focused on <b>Innovative Medicine</b> (pharmaceuticals) and <b>MedTech</b> (medical devices), having completed the spin-off of its Consumer Health division (Kenvue) in 2023. The company serves patients, healthcare professionals, and consumers across more than 175 countries worldwide, maintaining its position as a healthcare industry leader through continuous innovation and strategic acquisitions.

Similar companies

Latest newsMore news →